Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
- Biotech or pharma, therapeutic R&D
Alphamab Oncology is a clinical-stage biopharmaceutical company focusing on innovative biological medicine for cancer patients. On December 12, 2019, the Company was listed on the mainboard of Hong Kong Stock Exchange with stock code 9966.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}